B-Flexion Fund Management (Jersey)

B-Flexion Fund Management (Jersey) is the regulated asset management entity within the broader B-Flexion group, which serves as the investment organization for Ernesto Bertarelli and his family. The Bertarelli wealth was generated from Serono, the Swiss biotechnology company founded by the family and sold to Merck KGaA in 2006. The group maintains multiple entities across Europe, with the Jersey fund manager handling regulated fund activities.

The Jersey Financial Services Commission regulates B-Flexion Fund Management (Jersey), which implies the structure can manage pooled vehicles or third-party capital in addition to family money. The broader B-Flexion group, however, was built to institutionalize the Bertarelli family's wealth rather than to operate as a commercial asset gatherer. The exact mix of proprietary family capital versus external investor commitments is not publicly disclosed.

Waypoint Capital and B-Flexion operate as distinct but related entities within the Bertarelli family's investment ecosystem. Waypoint Capital is often described as the family's Geneva-based investment adviser, while B-Flexion entities handle fund management and structuring functions in regulated jurisdictions including Jersey and Luxembourg. Together they form a multi-jurisdictional architecture for deploying family capital.

The firm appears to use both approaches. Available public disclosures indicate a mix of direct co-investments in private companies, particularly in life sciences and healthcare, alongside commitments to external fund managers for other asset classes and geographies. The regulated Jersey structure allows the group to access institutional-grade fund vehicles managed externally.

B-Flexion does not publicly disclose assets under management. Media estimates of the Bertarelli family fortune derived from the Serono sale and subsequent investments have varied over time, but no verified figure for the Jersey entity exists in public filings. Institutional counterparties typically receive this information through direct due diligence.